Purchase Order 19GG8025P0544
Award Date
8/8/25
Potential Completion Date
5/30/26
Potential Value
$71K
Funding Federal Agency
Department of the Army
Contracting Federal Agency
US Embassy Tbilisi
Awardee
Elta 90 Medical Genetics LLC
Ultimate Awardee
Not listed
NAICS Category
339113 - Surgical Appliance and Supplies Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Georgia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Elta 90 Medical Genetics LLC, a for-profit limited liability company located in Tbilisi, Georgia. The contract is for the procurement of a MiSeq i100 Plus System, a specialized benchtop next-generation genetic sequencing instrument, at a ceiling value of $128,120.62. The equipment will be delivered to Tbilisi, Georgia to support ongoing research efforts at the Walter Reed Army Institute of Research (WRAIR). The...
The Defense Health Agency awarded a $30,890 firm-fixed-price delivery order to Elta 90 Medical Genetics LLC, a small business joint venture, for the supply of MISEQ REAGENT KIT V2 500 CYCLE. This award is part of a single-award Indefinite Delivery Contract (IDC) held by Elta 90 Medical Genetics LLC with the Defense Health Agency, with a ceiling value of $688,126 and an ultimate completion date of December 31, 2027. The IDC is for the procurement of MINISEQ DEVICE, indicating that Elta 90 Medical...
The Defense Health Agency awarded a firm-fixed-price purchase order contract to Elta 90 Medical Genetics LLC, a small business joint venture, for the WRAIR_MISEQ MAINTENANCE CONTRACT. The contract has a ceiling value of $120,059 and a period of performance through March 19, 2026. Elta 90 Medical Genetics LLC is a for-profit limited liability company that specializes in providing genetic sequencing equipment, supplies, and maintenance services to defense agencies. This contract is not set aside...
Elta 90 Medical Genetics LLC has been awarded a $122,000 firm fixed price purchase order by the Defense Advanced Research Projects Agency (DARPA) to provide WRAIR_ILLUMINA MISEQ services. The contract has a period of performance from August 17, 2023 through September 30, 2023, with work to be conducted in Gürcistan. DARPA's high-level programs involve advancing technologies with potential military applications, suggesting this contract supports research using next-generation DNA sequencing...
<p>The WRAIR_MISEQ_MAINTENANCE CONTRACT is a federal purchase order awarded by the Defense Advanced Research Projects Agency (DARPA) to Elta 90 Medical Genetics LLC, a for-profit limited liability company. The contract is for firm fixed-price maintenance services and has a potential value of $69,720.00. The contract does not have a set-aside designation and will be performed in Georgia. The contract has a completion date of February 14, 2025.</p>
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $581,761.93, is for the provision of support plans and reagent kits for the NextSeq equipment located at the Walter Reed Army Institute of Research (WRAIR) facility in Silver Spring, Maryland. The contract has an ultimate completion date of October 1, 2024....
This firm fixed-price purchase order, valued at $2,881,079.36, was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract supports genomic sequencing and analysis needs, with Illumina providing a range of sequencing systems, reagents, and bioinformatics products. This award does not have a set-aside designation. Illumina has previously received prime contract and subcontract awards from various federal...
This is a firm fixed-price purchase order contract awarded by the Medical Command (MEDCOM) component of the U.S. Army to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The contract, valued at $88,306.80, is for maintenance services on Illumina's sequencing systems. The award does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts to provide a range of its sequencing products and services,...
The U.S. Department of the Army's Medical Command (MEDCOM) awarded a Blanket Purchase Agreement (BPA) call order to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents, for the delivery of a SEQ 100 Sequencing System and associated supplies. The contract, valued at $60,300.26, is a firm fixed price award with no set-aside designation. Illumina has previously received prime and subcontract awards from various federal agencies, including the NIH, CDC, USDA, and VA, to provide...
This is a firm fixed price purchase order awarded by the Department of the Army Medical Command to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the provision of ILLUMINA REAGENTS FOR USACEHR. The $429,892.20 contract has a completion date of December 4, 2017. Illumina has previously provided sequencing systems, reagents, and related services to support genomic research and diagnostics for various federal agencies. This award does not have a set-aside...